CN104592337B - A kind of preparation method of 9- β-D- arabinofuranosidases glycosyl -2- fluoro adenine -5 '-phosphate - Google Patents
A kind of preparation method of 9- β-D- arabinofuranosidases glycosyl -2- fluoro adenine -5 '-phosphate Download PDFInfo
- Publication number
- CN104592337B CN104592337B CN201310528769.6A CN201310528769A CN104592337B CN 104592337 B CN104592337 B CN 104592337B CN 201310528769 A CN201310528769 A CN 201310528769A CN 104592337 B CN104592337 B CN 104592337B
- Authority
- CN
- China
- Prior art keywords
- fludarabine
- phosphate
- fludarabine phosphate
- white solid
- water
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Active
Links
- 238000002360 preparation method Methods 0.000 title claims abstract description 25
- 125000003147 glycosyl group Chemical group 0.000 title abstract description 8
- 229910019142 PO4 Inorganic materials 0.000 title abstract description 6
- 239000010452 phosphate Substances 0.000 title abstract description 5
- XLYOFNOQVPJJNP-UHFFFAOYSA-N water Substances O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 claims abstract description 71
- XHXFXVLFKHQFAL-UHFFFAOYSA-N phosphoryl trichloride Chemical compound ClP(Cl)(Cl)=O XHXFXVLFKHQFAL-UHFFFAOYSA-N 0.000 claims abstract description 54
- 238000006243 chemical reaction Methods 0.000 claims abstract description 27
- DQWPFSLDHJDLRL-UHFFFAOYSA-N triethyl phosphate Chemical compound CCOP(=O)(OCC)OCC DQWPFSLDHJDLRL-UHFFFAOYSA-N 0.000 claims abstract description 22
- GIUYCYHIANZCFB-FJFJXFQQSA-N fludarabine phosphate Chemical compound C1=NC=2C(N)=NC(F)=NC=2N1[C@@H]1O[C@H](COP(O)(O)=O)[C@@H](O)[C@@H]1O GIUYCYHIANZCFB-FJFJXFQQSA-N 0.000 claims description 100
- 239000007787 solid Substances 0.000 claims description 81
- HEMHJVSKTPXQMS-UHFFFAOYSA-M Sodium hydroxide Chemical compound [OH-].[Na+] HEMHJVSKTPXQMS-UHFFFAOYSA-M 0.000 claims description 75
- 229960005304 fludarabine phosphate Drugs 0.000 claims description 65
- YMWUJEATGCHHMB-UHFFFAOYSA-N Dichloromethane Chemical compound ClCCl YMWUJEATGCHHMB-UHFFFAOYSA-N 0.000 claims description 49
- 238000005406 washing Methods 0.000 claims description 38
- 229960000390 fludarabine Drugs 0.000 claims description 36
- 239000012043 crude product Substances 0.000 claims description 35
- 239000012065 filter cake Substances 0.000 claims description 34
- 238000001914 filtration Methods 0.000 claims description 31
- LFQSCWFLJHTTHZ-UHFFFAOYSA-N Ethanol Chemical compound CCO LFQSCWFLJHTTHZ-UHFFFAOYSA-N 0.000 claims description 30
- XEKOWRVHYACXOJ-UHFFFAOYSA-N Ethyl acetate Chemical group CCOC(C)=O XEKOWRVHYACXOJ-UHFFFAOYSA-N 0.000 claims description 24
- 239000000706 filtrate Substances 0.000 claims description 21
- 238000003756 stirring Methods 0.000 claims description 20
- 238000002425 crystallisation Methods 0.000 claims description 16
- 230000008025 crystallization Effects 0.000 claims description 16
- VEXZGXHMUGYJMC-UHFFFAOYSA-N Hydrochloric acid Chemical compound Cl VEXZGXHMUGYJMC-UHFFFAOYSA-N 0.000 claims description 14
- 238000013019 agitation Methods 0.000 claims description 14
- 238000001556 precipitation Methods 0.000 claims description 14
- KWYUFKZDYYNOTN-UHFFFAOYSA-M Potassium hydroxide Chemical compound [OH-].[K+] KWYUFKZDYYNOTN-UHFFFAOYSA-M 0.000 claims description 8
- 229940072033 potash Drugs 0.000 claims description 8
- BWHMMNNQKKPAPP-UHFFFAOYSA-L potassium carbonate Substances [K+].[K+].[O-]C([O-])=O BWHMMNNQKKPAPP-UHFFFAOYSA-L 0.000 claims description 8
- 235000015320 potassium carbonate Nutrition 0.000 claims description 8
- 239000002904 solvent Substances 0.000 claims description 8
- 239000011541 reaction mixture Substances 0.000 claims description 3
- 230000015572 biosynthetic process Effects 0.000 claims description 2
- 238000003786 synthesis reaction Methods 0.000 claims description 2
- 235000019441 ethanol Nutrition 0.000 claims 2
- 239000007788 liquid Substances 0.000 claims 1
- 238000000034 method Methods 0.000 abstract description 18
- 239000000203 mixture Substances 0.000 abstract description 13
- 230000008569 process Effects 0.000 abstract description 10
- 238000000746 purification Methods 0.000 abstract description 9
- 230000035484 reaction time Effects 0.000 abstract description 7
- 238000010189 synthetic method Methods 0.000 abstract description 7
- 238000012805 post-processing Methods 0.000 abstract description 4
- 239000007858 starting material Substances 0.000 abstract description 2
- WKMPTBDYDNUJLF-UHFFFAOYSA-N 2-fluoroadenine Chemical compound NC1=NC(F)=NC2=C1N=CN2 WKMPTBDYDNUJLF-UHFFFAOYSA-N 0.000 abstract 3
- NBIIXXVUZAFLBC-UHFFFAOYSA-K phosphate Chemical compound [O-]P([O-])([O-])=O NBIIXXVUZAFLBC-UHFFFAOYSA-K 0.000 abstract 2
- 239000000243 solution Substances 0.000 description 36
- 239000000047 product Substances 0.000 description 21
- 238000004128 high performance liquid chromatography Methods 0.000 description 13
- YXFVVABEGXRONW-UHFFFAOYSA-N Toluene Chemical compound CC1=CC=CC=C1 YXFVVABEGXRONW-UHFFFAOYSA-N 0.000 description 12
- 238000007605 air drying Methods 0.000 description 12
- 238000001514 detection method Methods 0.000 description 12
- YCKRFDGAMUMZLT-UHFFFAOYSA-N Fluorine atom Chemical compound [F] YCKRFDGAMUMZLT-UHFFFAOYSA-N 0.000 description 9
- 229910052731 fluorine Inorganic materials 0.000 description 9
- 239000011737 fluorine Substances 0.000 description 9
- 239000011347 resin Substances 0.000 description 7
- 229920005989 resin Polymers 0.000 description 7
- CSCPPACGZOOCGX-UHFFFAOYSA-N Acetone Chemical compound CC(C)=O CSCPPACGZOOCGX-UHFFFAOYSA-N 0.000 description 6
- 239000005457 ice water Substances 0.000 description 5
- WVLBCYQITXONBZ-UHFFFAOYSA-N trimethyl phosphate Chemical compound COP(=O)(OC)OC WVLBCYQITXONBZ-UHFFFAOYSA-N 0.000 description 5
- 238000010908 decantation Methods 0.000 description 4
- 230000006837 decompression Effects 0.000 description 4
- 238000004809 thin layer chromatography Methods 0.000 description 4
- 230000000052 comparative effect Effects 0.000 description 3
- 238000004519 manufacturing process Methods 0.000 description 3
- OKTJSMMVPCPJKN-UHFFFAOYSA-N Carbon Chemical compound [C] OKTJSMMVPCPJKN-UHFFFAOYSA-N 0.000 description 2
- 239000002253 acid Substances 0.000 description 2
- 230000000259 anti-tumor effect Effects 0.000 description 2
- 239000007864 aqueous solution Substances 0.000 description 2
- 238000001816 cooling Methods 0.000 description 2
- 230000000694 effects Effects 0.000 description 2
- 238000005265 energy consumption Methods 0.000 description 2
- 238000010438 heat treatment Methods 0.000 description 2
- 239000000463 material Substances 0.000 description 2
- 238000005374 membrane filtration Methods 0.000 description 2
- VNWKTOKETHGBQD-UHFFFAOYSA-N methane Chemical compound C VNWKTOKETHGBQD-UHFFFAOYSA-N 0.000 description 2
- 239000002244 precipitate Substances 0.000 description 2
- 230000004224 protection Effects 0.000 description 2
- 238000005057 refrigeration Methods 0.000 description 2
- 238000000926 separation method Methods 0.000 description 2
- 210000004881 tumor cell Anatomy 0.000 description 2
- HBUBKKRHXORPQB-FJFJXFQQSA-N (2R,3S,4S,5R)-2-(6-amino-2-fluoro-9-purinyl)-5-(hydroxymethyl)oxolane-3,4-diol Chemical compound C1=NC=2C(N)=NC(F)=NC=2N1[C@@H]1O[C@H](CO)[C@@H](O)[C@@H]1O HBUBKKRHXORPQB-FJFJXFQQSA-N 0.000 description 1
- AVXURJPOCDRRFD-UHFFFAOYSA-N Hydroxylamine Chemical compound ON AVXURJPOCDRRFD-UHFFFAOYSA-N 0.000 description 1
- 206010054949 Metaplasia Diseases 0.000 description 1
- OAICVXFJPJFONN-UHFFFAOYSA-N Phosphorus Chemical compound [P] OAICVXFJPJFONN-UHFFFAOYSA-N 0.000 description 1
- KBQPEQMZFVCZKQ-UHFFFAOYSA-N [F].OP(O)(O)=O Chemical compound [F].OP(O)(O)=O KBQPEQMZFVCZKQ-UHFFFAOYSA-N 0.000 description 1
- AFCIMSXHQSIHQW-UHFFFAOYSA-N [O].[P] Chemical compound [O].[P] AFCIMSXHQSIHQW-UHFFFAOYSA-N 0.000 description 1
- PIOKUWLZUXUBCO-FJFJXFQQSA-N [[(2R,3S,4S,5R)-5-(6-amino-2-fluoropurin-9-yl)-3,4-dihydroxyoxolan-2-yl]methoxy-hydroxyphosphoryl] phosphono hydrogen phosphate Chemical class C1=NC=2C(N)=NC(F)=NC=2N1[C@@H]1O[C@H](COP(O)(=O)OP(O)(=O)OP(O)(O)=O)[C@@H](O)[C@@H]1O PIOKUWLZUXUBCO-FJFJXFQQSA-N 0.000 description 1
- 239000003005 anticarcinogenic agent Substances 0.000 description 1
- 210000003719 b-lymphocyte Anatomy 0.000 description 1
- 230000008901 benefit Effects 0.000 description 1
- 230000015556 catabolic process Effects 0.000 description 1
- 230000008859 change Effects 0.000 description 1
- 238000012512 characterization method Methods 0.000 description 1
- 238000004587 chromatography analysis Methods 0.000 description 1
- 230000001684 chronic effect Effects 0.000 description 1
- 238000000354 decomposition reaction Methods 0.000 description 1
- 238000006731 degradation reaction Methods 0.000 description 1
- 125000003963 dichloro group Chemical group Cl* 0.000 description 1
- 238000005516 engineering process Methods 0.000 description 1
- 230000007613 environmental effect Effects 0.000 description 1
- 238000003912 environmental pollution Methods 0.000 description 1
- 150000002148 esters Chemical class 0.000 description 1
- 239000000284 extract Substances 0.000 description 1
- 238000000605 extraction Methods 0.000 description 1
- 238000011049 filling Methods 0.000 description 1
- 239000012467 final product Substances 0.000 description 1
- 239000003292 glue Substances 0.000 description 1
- 230000003834 intracellular effect Effects 0.000 description 1
- 230000002147 killing effect Effects 0.000 description 1
- 208000032839 leukemia Diseases 0.000 description 1
- 239000006210 lotion Substances 0.000 description 1
- 230000001926 lymphatic effect Effects 0.000 description 1
- 230000007246 mechanism Effects 0.000 description 1
- 230000015689 metaplastic ossification Effects 0.000 description 1
- KKZJGLLVHKMTCM-UHFFFAOYSA-N mitoxantrone Chemical compound O=C1C2=C(O)C=CC(O)=C2C(=O)C2=C1C(NCCNCCO)=CC=C2NCCNCCO KKZJGLLVHKMTCM-UHFFFAOYSA-N 0.000 description 1
- 229960001156 mitoxantrone Drugs 0.000 description 1
- 238000002156 mixing Methods 0.000 description 1
- 230000004048 modification Effects 0.000 description 1
- 238000012986 modification Methods 0.000 description 1
- 238000010899 nucleation Methods 0.000 description 1
- 230000006911 nucleation Effects 0.000 description 1
- 238000011017 operating method Methods 0.000 description 1
- 239000003960 organic solvent Substances 0.000 description 1
- 229910052698 phosphorus Inorganic materials 0.000 description 1
- 239000011574 phosphorus Substances 0.000 description 1
- 229920001467 poly(styrenesulfonates) Polymers 0.000 description 1
- 229940002612 prodrug Drugs 0.000 description 1
- 239000000651 prodrug Substances 0.000 description 1
- 238000001953 recrystallisation Methods 0.000 description 1
- 238000007670 refining Methods 0.000 description 1
- 159000000000 sodium salts Chemical class 0.000 description 1
- 239000012265 solid product Substances 0.000 description 1
- VIDRYROWYFWGSY-UHFFFAOYSA-N sotalol hydrochloride Chemical compound Cl.CC(C)NCC(O)C1=CC=C(NS(C)(=O)=O)C=C1 VIDRYROWYFWGSY-UHFFFAOYSA-N 0.000 description 1
- 230000002269 spontaneous effect Effects 0.000 description 1
- 239000000126 substance Substances 0.000 description 1
- DPJRMOMPQZCRJU-UHFFFAOYSA-M thiamine hydrochloride Chemical compound Cl.[Cl-].CC1=C(CCO)SC=[N+]1CC1=CN=C(C)N=C1N DPJRMOMPQZCRJU-UHFFFAOYSA-M 0.000 description 1
- 230000001988 toxicity Effects 0.000 description 1
- 231100000419 toxicity Toxicity 0.000 description 1
- 238000001291 vacuum drying Methods 0.000 description 1
Landscapes
- Saccharide Compounds (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
Abstract
The invention discloses a kind of preparation methods of 5 ' phosphate of 92 fluoro adenine of β D arabinofuranosidases glycosyls, this method is using 9 β D arabinofuranosidases glycosyl, 2 fluoro adenine as starting material, by making it be reacted with the mixture of triethyl phosphate and phosphorus oxychloride and being post-processed using water, it is harsh to solve reaction temperature in other synthetic methods, reaction time is long, the problem of post-processing operation complexity, the present invention includes a kind of simple simultaneously, feasible process for purification, effectively raise the purity of 92 fluoro adenine of β D arabinofuranosidases glycosyls, 5 ' phosphate.
Description
Technical field
The present invention relates to medicinal chemistry arts, and in particular to a kind of 9- β-D- arabinofuranosidases glycosyl -2- fluoro adenine -
The preparation method of 5 '-phosphates.
Background technology
Fludarabine phosphate（9- β-D- arabinofuranosidase glycosyl -2- fluoro adenine -5 '-phosphate）, English name；
Fludarabine phosphate, molecular formula：C10H13FN5O7P, molecular weight：365.2117 structural formula is：
It is developed, is listed in the U.S. first by German Berlex Labs within 1991, it is thin for treating B cell chronic lymphatic
Born of the same parents' leukaemia (CLL).Through going phosphatizing to generate metabolin 9- β-fludarabine (F-Ara-A), Hou Zhe after this product intake
The intracellular phosphorylated F-Ara-ATP for becoming to have antitumor activity.The antitumor mechanism of this product is related to participating in DNA of tumor cell
Or RNA chains, make chain stop extending, to achieve the purpose that DNA or RNA is inhibited to synthesize.This product and other anticarcinogen cytarabines
(Ara-C), the combinations such as mitoxantrone can enhance the killing effect to tumour cell.
It is with 9- β-D- arabinofuranosidase glycosyl -2- fluoro adenines（Fludarabine）For prodrug, structural formula
For；
The preparation of fludarabine phosphate is found in many patent documents, all of which using fludarabine as starting material into
It is prepared by row.
US5110919 uses the method that trimethyl phosphate and phosphorus oxychloride are reacted at 0 DEG C, the method for post-processing
It is that water and dichloromethane is added, stands arrive two-phase laminated flow under stiring, removes dichloromethane with decantation, obtain lurid glue
Shape residue is dissolved in 50 DEG C of hot water and remains to precipitate.Unique characterization of obtained crude product is decomposition point（200℃-250
℃）, with thin layer chromatography, secondary output object is recycled by resin, obtained solid is recrystallized with water.
The shortcomings that this method is that decantation operation is difficult to realize in industrially scale, is advised in industry in addition, can also generate
The gelatinous residue brought a lot of trouble is stirred on mould to reactor, and is purified using chromatography, complicated for operation, yield is low.
US4357324 uses trimethyl phosphate and phosphorus oxychloride and is reacted at 0 DEG C again, is hydrolyzed with water, generates sodium salt
Then the method for the latter being converted to free acid.
The yield that the method that the patent uses obtains is general, it is hard to which commercial scale reproduces, and this method is in extraction stages
Using azanol, the chemicals that may be exploded, therefore unsuitable large-scale use have been used.
CN200480030273.5 is put into using triethyl phosphate and fludarabine in -15/-20 DEG C of reactors, by trichlorine
Oxygen phosphorus was added dropwise to about one hour ground time, was reacted 48 hours at -10/-15 DEG C, and cold toluene, which is added, makes product precipitate slightly
Product, then with purifying resin, recrystallization.
The shortcomings that this method is that reaction temperature is low, and the reaction time is long, and energy consumption is big；Phosphorus oxychloride needs to be added dropwise, dangerous
Greatly, difficult operation；It uses toluene, toxicity to increase in last handling process, in addition uses purifying resin, it is complicated for operation, it is unfavorable for work
Industry metaplasia is produced.
Invention content
Harsh for the reaction temperature of the prior art, the reaction time is long, the problem of post-processing operation complexity, the present invention one
Purpose is to provide a kind of fludarabine phosphate synthetic method.
It is a further object of the present invention to provide a kind of process for purification of fludarabine phosphate crude product, to solve process for purification
Middle to cross resin column, chromatographic column, purification step is cumbersome, and high temperature is water-soluble to cause fludarabine phosphate rotten degradation in part to generate newly miscellaneous
The problems such as matter, not high enough purity.
The purpose of the present invention is what is be achieved through the following technical solutions：
A kind of synthetic method of fludarabine phosphate, synthesis step is as follows,
A. fludarabine and triethyl phosphate and phosphorus oxychloride reaction；B. water is added to mixing species obtained by the reaction, it is raw
At fludarabine phosphate.
Specially：The step a include under agitation by fludarabine, triethyl phosphate and phosphorus oxychloride less than
It is reacted at a temperature of 0 DEG C；The step b is included in, and pure water is added under stiring in gained reaction mixture less than 20 DEG C, is used
Solvent washing, gained water phase is adjusted to pH=2-3 with alkaline matter after washing, is concentrated under reduced pressure, and refrigerates crystallization, filtering, and filter cake is used a small amount of
Ethyl alcohol and water washing obtain fludarabine phosphate crude product.
It washs solvent for use in the step b to wash for dichloromethane, gained water phase is adjusted to 50%NaOH solution after washing
pH=3。
In the step b wash solvent for use washed for ethyl acetate, after washing gained water phase with potash solid be adjusted to pH=
2~3.
For every gram of fludarabine, the dosage of triethyl phosphate is 9~15mL, more preferable 11~12mL, further preferably
For 11.5mL；For every gram of fludarabine, dosage preferably 0.6~1.2mL, the more preferable 0.7~0.9mL of phosphorus oxychloride, into one
Step is preferably 0.75mL.
Reaction is being carried out less than 0 DEG C, is preferably carried out at -5 DEG C~-1 DEG C；
Reaction time is that can reflect within 12~24 hours completely；
For every gram of fludarabine, the dosage of water is preferably 5~30mL, more preferably 10~11mL.
Using synthetic method provided by the invention, effect is significant, greatly reduces operating procedure, and solvent disappears
Consumption, the reaction time is short, and purity is higher than 99%, and yield is higher than 70%, to save the energy, reduces production cost, reduces pair
In addition the load of instrument and equipment uses the solvent of environmental protection, the reaction is made to be more suitable for industrialized production.
The invention also discloses a kind of process for purification of fludarabine phosphate, include the following steps,
The fludarabine phosphate crude product that above-mentioned synthetic method is obtained, is added in pure water stirs evenly at room temperature, slowly
It is complete to dissolving that 50%NaOH solution is added dropwise, filters, in filtrate added drop-wise to dilute hydrochloric acid solution, there is white solid precipitation, filter, filter
Cake ethyl alcohol and water washing, obtain white solid, and white solid is dried in vacuo 10~12 hours at 45~50 DEG C, obtains phosphoric acid fluorine
Up to drawing shore.
Fludarabine phosphate synthetic method provided by the invention is to react in a mild condition, and the reaction time is short, after reaction
Handle simple to operation, harsh to solve in other synthetic methods reaction temperature, the reaction time is long, and energy consumption is big, post-processing behaviour
Make the problems such as complicated.
The process for purification of the present invention, refining effect is significant.Process for purification provided by the invention first, condition temperature
With energy saving, easy to operate, the used time is short, high income, does not use organic solvent, environmental pollution small；Secondly fludarabine phosphate
Stablize in this subtractive process, therefore the process for purification of the present invention has easy to operate, high income, purity is high, and stability is good
Feature, the fludarabine phosphate appearance obtained using process for purification disclosed by the invention is good, and purity is high（≥99.9%）.
Specific implementation mode
The present invention and advantage are illustrated by the following examples, and those of ordinary skill in the art make the present invention
It is obvious change and modification be also contained within the present invention.
Embodiment 1
Under agitation by fludarabine（10g）, triethyl phosphate（115mL）, phosphorus oxychloride（7.5mL）It is placed in -5
In~-10 DEG C of low-temperature circulating pump, while to keep internal temperature -5~-1 DEG C；It is stirred to react at -5~-1 DEG C 15 hours；
When the amount of fludarabine is in HPLC area of detection, think that the reaction was complete less than 2%, then by pure water（105mL）Under stiring
It is added in gained mixture, is washed with dichloromethane, gained water phase is adjusted to pH=3 with 50%NaOH solution, and 35-40 DEG C of decompression is dense
Contracting refrigerates crystallization, and filtering, filter cake a small amount of ethyl alcohol and water washing obtain white solid, by white solid at 45-50 DEG C vacuum
It is 10-12 hours dry, obtain fludarabine phosphate crude product purity 99.1%, yield 74.2%.
The fludarabine phosphate crude product that above-mentioned preparation method is obtained, is added in 100mL pure water and stirs evenly at room temperature,
It is complete to dissolving that 50%NaOH solution is slowly added dropwise, filtering, filtrate room temperature is added drop-wise in dilute hydrochloric acid solution, there is white solid precipitation,
Filter, filter cake a small amount of ethyl alcohol and water washing obtain white solid, by white solid at 45-50 DEG C vacuum forced air drying 10-12
Hour, obtain fludarabine phosphate highly finished product, purity 99.9%, yield 96.2%.
Embodiment 2
Under agitation by fludarabine（10g）, triethyl phosphate（90mL）, phosphorus oxychloride（6mL）It is placed in -5~-10
DEG C low-temperature circulating pump in, while to keep internal temperature -5~-1 DEG C；It is stirred to react at -5~-1 DEG C 15 hours；When fluorine reaches
It draws the amount of shore in HPLC area of detection, thinks that the reaction was complete less than 2%, then by pure water（50mL）Institute is added under stiring
It obtains in mixture, is washed with dichloromethane, gained water phase is adjusted to pH=3,35-40 DEG C of reduced pressure, refrigeration with 50%NaOH solution
Crystallization, filtering, filter cake a small amount of ethyl alcohol and water washing obtain white solid, white solid are dried in vacuo 10- at 45-50 DEG C
12 hours, obtain fludarabine phosphate crude product purity 99.2%, yield 73.3%.
The fludarabine phosphate crude product that above-mentioned preparation method is obtained, is added in 100mL pure water and stirs evenly at room temperature,
It is complete to dissolving that 50%NaOH solution is slowly added dropwise, filtering, filtrate room temperature is added drop-wise in dilute hydrochloric acid solution, there is white solid precipitation,
Filter, filter cake a small amount of ethyl alcohol and water washing obtain white solid, by white solid at 45-50 DEG C vacuum forced air drying 10-12
Hour, obtain fludarabine phosphate highly finished product, purity 99.9%, yield 96.5%.
Embodiment 3
Under agitation by fludarabine（10g）, triethyl phosphate（150mL）, phosphorus oxychloride（12mL）It is placed in -5~-
In 10 DEG C of low-temperature circulating pump, while to keep internal temperature -5~-1 DEG C；It is stirred to react at -5~-1 DEG C 15 hours；Work as fluorine
Think that the reaction was complete less than 2%, then by pure water in HPLC area of detection up to the amount of shore is drawn（200mL）It is added under stiring
It in gained mixture, is washed with dichloromethane, gained water phase is adjusted to pH=3 with 50%NaOH solution, and 35-40 DEG C of reduced pressure is cold
Crystallization is hidden, filtering, filter cake a small amount of ethyl alcohol and water washing obtain white solid, white solid are dried in vacuo at 45 DEG C -50 DEG C
10-12 hours, obtain fludarabine phosphate crude product purity 99.1%, yield 71%.
The fludarabine phosphate crude product that above-mentioned preparation method is obtained, is added in 100mL pure water and stirs evenly at room temperature,
It is complete to dissolving that 50%NaOH solution is slowly added dropwise, filtering, filtrate room temperature is added drop-wise in dilute hydrochloric acid solution, there is white solid precipitation,
Filter, filter cake a small amount of ethyl alcohol and water washing obtain white solid, by white solid at 45-50 DEG C vacuum forced air drying 10-12
Hour, obtain fludarabine phosphate highly finished product, purity 99.9%, yield 96.2%.
Embodiment 4
Under agitation by fludarabine（10g）, triethyl phosphate（110mL）, phosphorus oxychloride（7mL）It is placed in -5~-
In 10 DEG C of low-temperature circulating pump, while to keep internal temperature -5~-1 DEG C；It is stirred to react at -5~-1 DEG C 15 hours；Work as fluorine
Think that the reaction was complete less than 2%, then by pure water in HPLC area of detection up to the amount of shore is drawn（100mL）It is added under stiring
It in gained mixture, is washed with dichloromethane, gained water phase is adjusted to pH=3 with 50%NaOH solution, and 35-40 DEG C of reduced pressure is cold
Crystallization is hidden, filtering, filter cake a small amount of ethyl alcohol and water washing obtain white solid, white solid are dried in vacuo at 45-50 DEG C
10-12 hours, obtain fludarabine phosphate crude product purity 99.2%, yield 72.3%.
The fludarabine phosphate crude product that above-mentioned preparation method is obtained, is added in 100mL pure water and stirs evenly at room temperature,
It is complete to dissolving that 50%NaOH solution is slowly added dropwise, filtering, filtrate room temperature is added drop-wise in dilute hydrochloric acid solution, there is white solid precipitation,
Filter, filter cake a small amount of ethyl alcohol and water washing obtain white solid, by white solid at 45-50 DEG C vacuum forced air drying 10-12
Hour, obtain fludarabine phosphate highly finished product, purity 99.9%, yield 95.1%.
Embodiment 5
Under agitation by fludarabine（10g）, triethyl phosphate（120mL）, phosphorus oxychloride（9mL）It is placed in -5~-
In 10 DEG C of low-temperature circulating pump, while to keep internal temperature -5~-1 DEG C；It is stirred to react at -5~-1 DEG C 15 hours；Work as fluorine
Think that the reaction was complete less than 2%, then by pure water in HPLC area of detection up to the amount of shore is drawn（110mL）It is added under stiring
It in gained mixture, is washed with dichloromethane, gained water phase is adjusted to pH=3 with 50%NaOH solution, and 35-40 DEG C of reduced pressure is cold
Crystallization is hidden, filtering, filter cake a small amount of ethyl alcohol and water washing obtain white solid, white solid are dried in vacuo at 45-50 DEG C
10-12 hours, obtain fludarabine phosphate crude product purity 99.1%, yield 73%.
The fludarabine phosphate crude product that above-mentioned preparation method is obtained, is added in 100mL pure water and stirs evenly at room temperature,
It is complete to dissolving that 50%NaOH solution is slowly added dropwise, filtering, filtrate room temperature is added drop-wise in dilute hydrochloric acid solution, there is white solid precipitation,
Filter, filter cake a small amount of ethyl alcohol and water washing obtain white solid, by white solid at 45-50 DEG C vacuum forced air drying 10-12
Hour, obtain fludarabine phosphate highly finished product, purity 99.9%, yield 95.4%.
Embodiment 6
Fludarabine 10g is suspended in trimethyl phosphate 100mL, ice-water bath is cooled to 0 DEG C, phosphorus oxychloride is slowly added dropwise
7.2mL.Drop finishes, and 0 DEG C is reacted 30 hours, and TLC shows that the reaction was complete；Water and dichloromethane is added, stands arrive two-phase under stiring
Separation removes dichloromethane with decantation, obtains lurid gelatinous residue, be dissolved in 50 DEG C of hot water and remain to precipitate.Institute
Obtained crude product filters, and filtrate is concentrated under reduced pressure and obtains white solid, purity 95.3%, yield 58.1%.
The fludarabine phosphate crude product that above-mentioned preparation method is obtained, is added in 100mL pure water and stirs evenly at room temperature,
It is complete to dissolving that 50%NaOH solution is slowly added dropwise, filtering, filtrate room temperature is added drop-wise in dilute hydrochloric acid solution, there is white solid precipitation,
Filter, filter cake a small amount of ethyl alcohol and water washing obtain white solid, by white solid at 45-50 DEG C vacuum forced air drying 10-12
Hour, obtain fludarabine phosphate highly finished product, purity 99.9%, yield 95.2%.
Embodiment 7
Under agitation by fludarabine（10g）, triethyl phosphate（115mL）, phosphorus oxychloride（7.5mL）It is placed in -5
In~-10 DEG C of low-temperature circulating pump, while to keep internal temperature -5~-1 DEG C；It is stirred to react at -5~-1 DEG C 15 hours；
When the amount of fludarabine is in HPLC area of detection, think that the reaction was complete less than 2%, then by pure water（105mL）Under stiring
It is added in gained mixture, is washed with dichloromethane, gained water phase is adjusted to pH=3 with 50%NaOH solution, and 35-40 DEG C of decompression is dense
Contracting refrigerates crystallization, and filtering, filter cake a small amount of ethyl alcohol and water washing obtain white solid, by white solid at 45-50 DEG C vacuum
It is 10-12 hours dry, obtain fludarabine phosphate crude product purity 99.1%, yield 71.1%.
The fludarabine phosphate crude product that above-mentioned preparation method is obtained, is suspended in the water of 25 volumes, by whole objects
Matter dissolves by heating at 65 DEG C, filters while hot, and filtrate is washed filter cake with acetone, obtained with ice-water bath cooling crystallization, filtering, filter cake
Product purity 99.2%, yield 80.3%.
Embodiment 8
Under agitation by fludarabine（10g）, triethyl phosphate（115mL）, phosphorus oxychloride（7.5mL）It is placed in -5
In~-10 DEG C of low-temperature circulating pump, while to keep internal temperature -5~-1 DEG C；It is stirred to react at -5~-1 DEG C 15 hours；
When the amount of fludarabine is in HPLC area of detection, think that the reaction was complete less than 2%, then by pure water（170mL）Under stiring
It is added in gained mixture, is washed with ethyl acetate, gained water phase is adjusted to pH=2 with potash solid, and 35~40 DEG C of decompressions are dense
Contracting refrigerates crystallization, and filtering, filter cake a small amount of ethyl alcohol and water washing obtain white solid, by white solid at 45~50 DEG C vacuum
It is 10~12 hours dry, obtain fludarabine phosphate crude product purity 99.2%, yield 72.9%.
The fludarabine phosphate crude product that above-mentioned preparation method is obtained, is added in 100mL pure water and stirs evenly at room temperature,
It is complete to dissolving that 50%NaOH solution is slowly added dropwise, filtering, filtrate room temperature is added drop-wise in dilute hydrochloric acid solution, there is white solid precipitation,
Filter, filter cake a small amount of ethyl alcohol and water washing obtain white solid, by white solid at 45~50 DEG C vacuum forced air drying 10~
12 hours, obtain fludarabine phosphate highly finished product, purity 99.9%, yield 94.6%.
Embodiment 9
Under agitation by fludarabine（10g）, triethyl phosphate（90mL）, phosphorus oxychloride（6mL）It is placed in -5~-10
DEG C low-temperature circulating pump in, while to keep internal temperature -5~-1 DEG C；It is stirred to react at -5~-1 DEG C 15 hours；When fluorine reaches
It draws the amount of shore in HPLC area of detection, thinks that the reaction was complete less than 2%, then by pure water（100mL）Institute is added under stiring
It obtains in mixture, is washed with ethyl acetate, gained water phase is adjusted to pH=2,35~40 DEG C of reduced pressures, refrigeration with potash solid
Crystallization, filtering, filter cake a small amount of ethyl alcohol and water washing obtain white solid, white solid are dried in vacuo 10 at 45~50 DEG C
~12 hours, obtain fludarabine phosphate crude product purity 99.2%, yield 70.2%.
The fludarabine phosphate crude product that above-mentioned preparation method is obtained, is added in 100mL pure water and stirs evenly at room temperature,
It is complete to dissolving that 50%NaOH solution is slowly added dropwise, filtering, filtrate room temperature is added drop-wise in dilute hydrochloric acid solution, there is white solid precipitation,
Filter, filter cake a small amount of ethyl alcohol and water washing obtain white solid, by white solid at 45~50 DEG C vacuum forced air drying 10~
12 hours, obtain fludarabine phosphate highly finished product, purity 99.9%, yield 95.2%.
Embodiment 10
Under agitation by fludarabine（10g）, triethyl phosphate（150mL）, phosphorus oxychloride（12mL）It is placed in -5~-
In 10 DEG C of low-temperature circulating pump, while to keep internal temperature -5~-1 DEG C；It is stirred to react at -5~-1 DEG C 15 hours；Work as fluorine
Think that the reaction was complete less than 2%, then by pure water in HPLC area of detection up to the amount of shore is drawn（300mL）It is added under stiring
It in gained mixture, is washed with ethyl acetate, gained water phase is adjusted to pH=2 with potash solid, and 35~40 DEG C of reduced pressures are cold
Crystallization, filtering are hidden, filter cake a small amount of ethyl alcohol and water washing obtain white solid, and vacuum is done at 45 DEG C~50 DEG C by white solid
Dry 10~12 hours, obtain fludarabine phosphate crude product purity 99.1%, yield 71.3%.
The fludarabine phosphate crude product that above-mentioned preparation method is obtained, is added in 100mL pure water and stirs evenly at room temperature,
It is complete to dissolving that 50%NaOH solution is slowly added dropwise, filtering, filtrate room temperature is added drop-wise in dilute hydrochloric acid solution, there is white solid precipitation,
Filter, filter cake a small amount of ethyl alcohol and water washing obtain white solid, by white solid at 45~50 DEG C vacuum forced air drying 10~
12 hours, obtain fludarabine phosphate highly finished product, purity 99.9%, yield 95.1%.
Embodiment 11
Under agitation by fludarabine（10g）, triethyl phosphate（110mL）, phosphorus oxychloride（7mL）It is placed in -5~-
In 10 DEG C of low-temperature circulating pump, while to keep internal temperature -5~-1 DEG C；It is stirred to react at -5~-1 DEG C 15 hours；Work as fluorine
Think that the reaction was complete less than 2%, then by pure water in HPLC area of detection up to the amount of shore is drawn（200mL）It is added under stiring
It in gained mixture, is washed with ethyl acetate, gained water phase is adjusted to pH=2 with potash solid, and 35~40 DEG C of reduced pressures are cold
Crystallization is hidden, filtering, filter cake a small amount of ethyl alcohol and water washing obtain white solid, white solid are dried in vacuo at 45~50 DEG C
10~12 hours, obtain fludarabine phosphate crude product purity 99.2%, yield 71.1%.
The fludarabine phosphate crude product that above-mentioned preparation method is obtained, is added in 100mL pure water and stirs evenly at room temperature,
It is complete to dissolving that 50%NaOH solution is slowly added dropwise, filtering, filtrate room temperature is added drop-wise in dilute hydrochloric acid solution, there is white solid precipitation,
Filter, filter cake a small amount of ethyl alcohol and water washing obtain white solid, by white solid at 45~50 DEG C vacuum forced air drying 10~
12 hours, obtain fludarabine phosphate highly finished product, purity 99.9%, yield 95.3%.
Embodiment 12
Under agitation by fludarabine（10g）, triethyl phosphate（120mL）, phosphorus oxychloride（9mL）It is placed in -5~-
In 10 DEG C of low-temperature circulating pump, while to keep internal temperature -5~-1 DEG C；It is stirred to react at -5~-1 DEG C 15 hours；Work as fluorine
Think that the reaction was complete less than 2%, then by pure water in HPLC area of detection up to the amount of shore is drawn（220mL）It is added under stiring
It in gained mixture, is washed with ethyl acetate, gained water phase is adjusted to pH=2 with potash solid, and 35~40 DEG C of reduced pressures are cold
Crystallization is hidden, filtering, filter cake a small amount of ethyl alcohol and water washing obtain white solid, white solid are dried in vacuo at 45~50 DEG C
10~12 hours, obtain fludarabine phosphate crude product purity 99.3%, yield 73.3%.
The fludarabine phosphate crude product that above-mentioned preparation method is obtained, is added in 100mL pure water and stirs evenly at room temperature,
It is complete to dissolving that 50%NaOH solution is slowly added dropwise, filtering, filtrate room temperature is added drop-wise in dilute hydrochloric acid solution, there is white solid precipitation,
Filter, filter cake a small amount of ethyl alcohol and water washing obtain white solid, by white solid at 45~50 DEG C vacuum forced air drying 10~
12 hours, obtain fludarabine phosphate highly finished product, purity 99.9%, yield 95.5%.
Embodiment 13
Fludarabine 10g is suspended in trimethyl phosphate 100mL, ice-water bath is cooled to 0 DEG C, phosphorus oxychloride is slowly added dropwise
7.2mL.Drop finishes, and 0 DEG C is reacted 30 hours, and TLC shows that the reaction was complete；Water and dichloromethane is added, stands arrive two-phase under stiring
Separation removes dichloromethane with decantation, obtains lurid gelatinous residue, be dissolved in 50 DEG C of hot water and remain to precipitate.Institute
Obtained crude product filters, and filtrate is concentrated under reduced pressure and obtains white solid, purity 95.3%, yield 58.1%.
The fludarabine phosphate crude product that above-mentioned preparation method is obtained, is added in 100mL pure water and stirs evenly at room temperature,
It is complete to dissolving that 50%NaOH solution is slowly added dropwise, filtering, filtrate room temperature is added drop-wise in dilute hydrochloric acid solution, there is white solid precipitation,
Filter, filter cake a small amount of ethyl alcohol and water washing obtain white solid, by white solid at 45-50 DEG C vacuum forced air drying 10-12
Hour, obtain fludarabine phosphate highly finished product, purity 99.9%, yield 95.2%.
Embodiment 14
Under agitation by fludarabine（10g）, triethyl phosphate（115mL）, phosphorus oxychloride（7.5mL）It is placed in -5
In~-10 DEG C of low-temperature circulating pump, while to keep internal temperature -5~-1 DEG C；It is stirred to react at -5~-1 DEG C 15 hours；
When the amount of fludarabine is in HPLC area of detection, think that the reaction was complete less than 2%, then by pure water（105mL）Under stiring
It is added in gained mixture, is washed with ethyl acetate, gained water phase is adjusted to pH=2 with potash solid, and 35~40 DEG C of decompressions are dense
Contracting refrigerates crystallization, and filtering, filter cake a small amount of ethyl alcohol and water washing obtain white solid, by white solid at 45~50 DEG C vacuum
It is 10~12 hours dry, obtain fludarabine phosphate crude product purity 99.2%, yield 71.2%.
The fludarabine phosphate crude product that above-mentioned preparation method is obtained, is suspended in the water of 25 volumes, by whole objects
Matter dissolves by heating at 65 DEG C, filters while hot, and filtrate is washed filter cake with acetone, obtained with ice-water bath cooling crystallization, filtering, filter cake
Product purity 99.4%, yield 82.4%.
Comparative example 1
Fludarabine 0.25g (0.88mmol) is suspended in triethyl phosphate 2.30mL (13.5mmol), Ar protections, ice water
Bath is cooled to 0 DEG C, and phosphorus oxychloride 0.18mL (1.95mmol) is slowly added dropwise.Drop finishes, and 0 DEG C is reacted 3.5 hours.It adds
POCI30.06mL (0.65mmol), continuation are reacted 5 hours at 0 DEG C, and TLC shows that the reaction was complete.Filtering, filter residue is washed with cold water,
Merge washing lotion and filtrate, be cooled to 0 DEG C, it is 2 that 50% (w) NaOH aqueous solutions, which are added dropwise, and adjust pH value, uses CH2Cl2It extracts (10mL × 2),
Water layer is again through 50% (w/w) NaOH aqueous solution tune pH=2.Activated carbon is added, is stirred at room temperature 1 hour, filters, filtrate is concentrated under reduced pressure and obtains
White solid recrystallizes to obtain 195mg white solids, yield 59.2% with water.
Comparative example 2
By 9.5g phosphorus oxychloride add to it is pre- be cooled in 0 DEG C of trimethyl phosphate, stir 40min after again by 10g mono- be hydrated fluorine
Up to drawing shore to add system, it is stirred to react after 3h gained homogeneous phase solution being placed in refrigerator and stands overnight.10ml is added in system
1.5g is stirred after water, is subsequently poured into the dichloromethane that 500ml is cooled to 0 DEG C in advance, and stirring is until dichloromethane layer is transparent.Pour out dichloro
100ml warm water stirring and dissolvings are added in residue for methane layer.Spontaneous nucleation obtains fludarabine phosphate 8.2g after vacuum drying, receive
Rate 58.3%.
Comparative example 3
By fludarabine（19.5g;0.0683 mole）With triethyl phosphate (79.1ml;0.465 mole）Be put into be cooled to-
DEG C reactor in.By phosphorus oxychloride (15.3ml;0.164 mole）It was added dropwise with about l hours time, is wanted simultaneously
Keep internal temperature at -10/-15 DEG C.It is stirred 48 hours at -10/-15 DEG C；When the amount of fludarabine, in HPLC areas,
Then think that reaction is complete when less than 2%.Then by cold toluene（780ml, 40 volumes）It is added, maintains in about 1.5 hours
Stirring remains at filterings in 1-2 hours, filter cake at -10/-15 DEG C and is washed with 20ml toluene.By wet solid（About 35g）It is suspended to
In 40ml water, with 32% NaOH（About 20ml）By pH be adjusted to 11. solution is filled into the beaker for filling Dowex resins
Resin must be activated and wash first as follows：With water washing is softened, until washings become colourless；With about 20ml5%'s
HCL is acidified, and pH neutrality is washed to softening ］.Total material stirs 15 minutes and uses membrane filtration.Resin is resuspended in
In 500ml water.Stirring then repeats this operation in 15 minutes with membrane filtration again, until there is no fludarabine phosphorus in filtrate
Until acid esters.By the partial vacuum volatilization containing product（30-35 DEG C of temperature highest）To reduce its volume, until desirable production
Object precipitates, and final product filters and is dried under vacuum to constant weight at 60 DEG C.Obtain the white solid product that purity is higher than 97.5%
10.1g（Yield 40%).This solid can be recrystallized as follows：It is suspended in the water of 10 volumes, by total material 70
It is heated 1 hour at DEG C, filters while hot, filter cake is washed with acetone, obtain product purity 99.0%.
Claims (6)
1. a kind of preparation method of fludarabine phosphate, which is characterized in that include the following steps：
1）Fludarabine phosphate crude product synthesizes：A. fludarabine and triethyl phosphate and phosphorus oxychloride reaction；B. to being obtained by the reaction
Mixture in water is added, so that fludarabine phosphate is precipitated；
2）Fludarabine phosphate is refined；
The step a includes the temperature by fludarabine, triethyl phosphate and phosphorus oxychloride at -5 DEG C~-1 DEG C under agitation
The lower reaction of degree；The step b is included in, and pure water is added under stiring in gained reaction mixture less than 20 DEG C, is washed with solvent
Wash, after washing gained water phase be adjusted to pH=2-3 with alkaline matter, be concentrated under reduced pressure, refrigerate crystallization, filtering, a small amount of ethyl alcohol of filter cake with
Water washing obtains fludarabine phosphate crude product；
In the step b wash solvent for use be dichloromethane wash, after washing obtained by water phase with 50%NaOH solution be adjusted to pH=
3。
2. the preparation method of fludarabine phosphate according to claim 1, which is characterized in that wash institute in the step b
It is ethyl acetate with solvent, gained water phase is adjusted to pH=2~3 with potash solid after washing.
3. the preparation method of fludarabine phosphate according to claim 1, which is characterized in that for every gram of fludarabine,
The dosage of triethyl phosphate is 9~15mL.
4. the preparation method of fludarabine phosphate according to claim 1, which is characterized in that for every gram of fludarabine,
0.6~1.2mL of dosage of phosphorus oxychloride.
5. the preparation method of fludarabine phosphate according to claim 1, which is characterized in that for every gram of fludarabine,
The dosage of water is 5~30mL.
6. the preparation method of fludarabine phosphate according to claim 1, which is characterized in that described refined including following step
Suddenly：The fludarabine phosphate crude product that synthesis is obtained, is added in pure water stirs evenly at room temperature, it is molten that 50%NaOH is slowly added dropwise
Liquid is complete to dissolving, filtering, in filtrate added drop-wise to dilute hydrochloric acid solution, there is white solid precipitation, filters, filter cake ethyl alcohol and washing
It washs, obtains white solid, white solid is dried in vacuo 10-12 hours at 45~50 DEG C, obtains fludarabine phosphate.
Priority Applications (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| CN201310528769.6A CN104592337B (en) | 2013-10-31 | 2013-10-31 | A kind of preparation method of 9- β-D- arabinofuranosidases glycosyl -2- fluoro adenine -5 '-phosphate |
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| CN201310528769.6A CN104592337B (en) | 2013-10-31 | 2013-10-31 | A kind of preparation method of 9- β-D- arabinofuranosidases glycosyl -2- fluoro adenine -5 '-phosphate |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| CN104592337A CN104592337A (en) | 2015-05-06 |
| CN104592337B true CN104592337B (en) | 2018-09-07 |
Family
ID=53118431
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| CN201310528769.6A Active CN104592337B (en) | 2013-10-31 | 2013-10-31 | A kind of preparation method of 9- β-D- arabinofuranosidases glycosyl -2- fluoro adenine -5 '-phosphate |
Country Status (1)
| Country | Link |
|---|---|
| CN (1) | CN104592337B (en) |
Families Citing this family (5)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US10669302B2 (en) | 2015-08-28 | 2020-06-02 | Zhejianf Hisun Pharmaceutical Co., Ltd. | Crystal form of fludarabine phosphate, preparation method therefor, and application thereof |
| CN105859812B (en) * | 2016-05-03 | 2019-07-26 | 河南师范大学 | A kind of preparation method of fludarabine phosphate |
| CN106083837B (en) * | 2016-05-27 | 2018-08-31 | 浙江普洛得邦制药有限公司 | The preparation method of Yi Zhong oxazolidinones antibacterials and its intermediate |
| CN110028538A (en) * | 2019-05-17 | 2019-07-19 | 连云港杰瑞药业有限公司 | A kind of drying means of fludarabine phosphate bulk pharmaceutical chemicals |
| CN115448966B (en) * | 2022-10-20 | 2024-10-15 | 海南锦瑞制药有限公司 | Preparation method of fludarabine phosphate and preparation method of fludarabine phosphate for injection |
Citations (3)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| WO1992000312A1 (en) * | 1990-06-27 | 1992-01-09 | Ash Stevens, Inc. | Process for the preparation of 9-beta-d-arabinofuranosyl-2-fluoroadenine 5'-phosphate |
| WO2004087939A1 (en) * | 2003-04-03 | 2004-10-14 | Pro.Bio.Sint. S.P.A. | A process for the preparation of fludarabine phosphate from 2-fluoroadenine and fludarabine phosphate salts with amines or ammonia |
| CN1867575A (en) * | 2003-10-15 | 2006-11-22 | 阿多凯姆技术有限公司 | Process for the preparation of fludarabine phosphate |
-
2013
- 2013-10-31 CN CN201310528769.6A patent/CN104592337B/en active Active
Patent Citations (3)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| WO1992000312A1 (en) * | 1990-06-27 | 1992-01-09 | Ash Stevens, Inc. | Process for the preparation of 9-beta-d-arabinofuranosyl-2-fluoroadenine 5'-phosphate |
| WO2004087939A1 (en) * | 2003-04-03 | 2004-10-14 | Pro.Bio.Sint. S.P.A. | A process for the preparation of fludarabine phosphate from 2-fluoroadenine and fludarabine phosphate salts with amines or ammonia |
| CN1867575A (en) * | 2003-10-15 | 2006-11-22 | 阿多凯姆技术有限公司 | Process for the preparation of fludarabine phosphate |
Non-Patent Citations (3)
| Title |
|---|
| 9-β-D-阿拉伯呋喃糖-2-氟腺苷单磷酸酯的合成改进;王悦球，等;《华东理工大学学报（自然科学版）》;20061231;第32卷(第12期);第1436-1439页 * |
| 抗肿瘤新药磷酸氟达拉宾的合成;田强，等;《化学研究与应用》;20060531;第18卷(第5期);第570-572页 * |
| 抗肿瘤药氟达拉滨的合成;张奎，等;《精细化工中间体》;20040831;第34卷(第4期);第33-35页 * |
Also Published As
| Publication number | Publication date |
|---|---|
| CN104592337A (en) | 2015-05-06 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| CN104592337B (en) | A kind of preparation method of 9- β-D- arabinofuranosidases glycosyl -2- fluoro adenine -5 '-phosphate | |
| CN101812095A (en) | Preparation method of sucralose | |
| CN111440170B (en) | Method for synthesizing guanine by using guanosine | |
| CN102395591B (en) | Method for preparing prasugrel | |
| CN102086222A (en) | Preparation method of beta-thymidine | |
| WO2021098847A1 (en) | Clindamycin phosphate purification method | |
| CN109320564B (en) | Preparation process of L-lyxose | |
| CN102153600A (en) | Method for preparing 2-deoxidation-L-ribose | |
| CN103319548B (en) | A kind of method of purification of cane sugar-6-acetic ester | |
| CN103408548B (en) | The method of synthesis (R)-9-(2-hydroxypropyl) VITAMIN B4 | |
| CN106397516B (en) | Cangrelor intermediate and its preparation method and application | |
| CN101108824A (en) | Method for synthesizing 2- chlorine -3- cyanogen radical pyridine with 3- cyanogen radical pyridine | |
| CN101492411A (en) | Improved method for preparation of mitiglinide | |
| CN103588765A (en) | Synthesis method for azilsartan medoxomil or salt thereof, intermediate of azilsartan medoxomil or salt thereof and synthesis method for intermediate | |
| CN103360412A (en) | A kind of synthetic method of S 578 | |
| CN101544576A (en) | Method for preparing fluorenylmethyloxycarbonyl-aspartate-alpha-allyl ester | |
| CN102070644A (en) | Method for preparing camptothecin derivatives and intermediates thereof | |
| CN101538214A (en) | Method for preparing gamma-butyrobetaine and hydrochloride thereof | |
| CN108070012B (en) | The method of 6 alpha-fluoro tetraene acetates of highly selective preparation | |
| CN101935317B (en) | Synthesizing method of 2-methyl-7-(substituted pyrimidine-4-amino)-4-(substituted piperazine-1-base) piperidine-1-base) isoindoline-1-ketone and intermediate thereof | |
| CN103113441A (en) | Method for preparing capecitabine | |
| CN105037348B (en) | A kind of Retapamulin synthetic method | |
| CN103951669A (en) | Synthesis method of Anagliptin key intermediate | |
| CN102199176A (en) | Preparation method for 2-amino-2-deoxy-D-glucose and salt thereof | |
| CN110003006A (en) | A kind of preparation method of sour 7 side chains of latamoxef |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| C06 | Publication | ||
| PB01 | Publication | ||
| C10 | Entry into substantive examination | ||
| SE01 | Entry into force of request for substantive examination | ||
| GR01 | Patent grant | ||
| GR01 | Patent grant | ||
| PE01 | Entry into force of the registration of the contract for pledge of patent right |
Denomination of invention: A 9- b- Preparation of d-arabinofuranosyl-2-fluoroadenine-5 '- phosphate Effective date of registration: 20211224 Granted publication date: 20180907 Pledgee: Industrial and Commercial Bank of China Limited Feixian sub branch Pledgor: SHANDONG NEW TIME PHARMACEUTICAL Co.,Ltd. Registration number: Y2021980016193 |
|
| PE01 | Entry into force of the registration of the contract for pledge of patent right | ||
| PC01 | Cancellation of the registration of the contract for pledge of patent right |
Date of cancellation: 20221028 Granted publication date: 20180907 Pledgee: Industrial and Commercial Bank of China Limited Feixian sub branch Pledgor: SHANDONG NEW TIME PHARMACEUTICAL Co.,Ltd. Registration number: Y2021980016193 |
|
| PC01 | Cancellation of the registration of the contract for pledge of patent right | ||
| PE01 | Entry into force of the registration of the contract for pledge of patent right |
Denomination of invention: One 9- b- Preparation of D-arabinose 2-fluoroadenine-5 '- phosphate Effective date of registration: 20221103 Granted publication date: 20180907 Pledgee: Industrial and Commercial Bank of China Limited Feixian sub branch Pledgor: SHANDONG NEW TIME PHARMACEUTICAL Co.,Ltd. Registration number: Y2022980020531 |
|
| PE01 | Entry into force of the registration of the contract for pledge of patent right |